We noticed that T1D patients showed remarkably higher concentrations of proinflammatory TGF-α (p < 0.001), TNF-α (p = 0.002), EGF (p < 0.001), eotaxin (p = 0.017), MDC (p = 0.036), and sCD40L (p = 0.002), which are presented in Figure 2A–F and Table 2. The gene discussed is CCL22; the disease is type 1 diabetes mellitus.